ASP Isotopes, Inc. ASPI 深 滬
等待開盤 02-12 09:30:00 美东时间
5.495
+0.025
+0.46%
華盛通- 最 高5.66
- 今 開5.55
- 成交量 208.89万股
- 最 低 5.2494
- 昨 收 5.47
- 總市值 1.76亿
- 52周最高 14.49
- 市盈率 靜 --
- 換手率 6.51%
- 52周最低 3.65
- 委 比 -16.98%
- 總股本 3210.71万
- 歷史最高 14.49
- 量 比 0.57
- 振 幅 7.51%
- 歷史最低 0.28
- 每 手 1
- 風險率 2.05%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ASPIsotopes Shares Spike Higher; Co Posts On X "ASP Isotopes is building our role as a core partner in the semiconductor supply chain—helping enable higher-performance computing while addressing the energy, cooling, and cost challenges that come with it. Through advanced materials and close collaboration with semiconductor and data-center leaders, we support innovation without compromising efficiency."
https://x.com/ASPIsotopes/status/2016208798613176401?s=20
01-28 02:04
How Is The Market Feeling About ASP Isotopes Inc?
ASP Isotopes Inc's (NYSE:ASPI) short interest as a percent of float has risen 8...
01-10 03:00
CG Oncology, Rich Sparkle Holdings, Liquidia And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Dow Jones index gaining around 200 points on ...
01-10 00:25
ASP Isotopes Obtains Regulatory Approvals And Clearances For Its Proposed Offer To Acquire Renergen; Shareholders To Receive 0.09196 ASPI Shares Per Renergen Share
ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries,ASP Isotopes Inc.
2025-12-17 22:32
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
2025-12-05 08:35
ASP Isotopes Founder Paul Mann To Return As CEO On January 19, 2026, After Health-Related Leave; Interim CEO Robert Ainscow To Resume COO-Only Role
ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries,
2025-12-02 22:18
美股大行评级 | 摩根大通上调百度至"超配"，目标价升至188美元！Navan获多家机构首予"买入"评级，目标价最高30美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从4美元升至9美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从32美元升至38美元
2025-11-25 10:27
Canaccord Genuity Maintains Buy on ASP Isotopes, Maintains $11 Price Target
Canaccord Genuity analyst George Gianarikas maintains ASP Isotopes (NASDAQ:ASPI) with a Buy and maintains $11 price target.
2025-11-24 22:45
ASP Isotopes shares are trading lower after the company reported worse-than-expected Q3 EPS results.
ASP Isotopes shares are trading lower after the company reported worse-than-exp...
2025-11-21 01:55
ASP Isotopes Q3 EPS $(0.15) Misses $(0.10) Estimate, Sales $4.890M Beat $2.248M Estimate
ASP Isotopes (NASDAQ:ASPI) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.10) by 50 percent. This is a 25 percent decrease over losses of $(0.12) per share from the same
2025-11-20 08:09
